POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE
Autoimmune mechanisms of Crohn’s disease have been extensively studied, following discovery of NOD2, ATG16L1, IRGM genetic polymorphisms associated with Crohn’s disease. These genes play an important role in innate immune response against intracellular bacteria, in particular, due to the...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2017-08-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/1317 |
_version_ | 1797197927871938560 |
---|---|
author | E. A. Shulenina E. V. Abakushina E. Yu. Lyssuk |
author_facet | E. A. Shulenina E. V. Abakushina E. Yu. Lyssuk |
author_sort | E. A. Shulenina |
collection | DOAJ |
description | Autoimmune mechanisms of Crohn’s disease have been extensively studied, following discovery of NOD2, ATG16L1, IRGM genetic polymorphisms associated with Crohn’s disease. These genes play an important role in innate immune response against intracellular bacteria, in particular, due to their direct participation in a process known as autophagy. Due to mentioned genetic traits, the CD patients are more susceptible to chronic infections caused by intracellular pathogens. Recent studies revealed high incidence of intracellular infection with Mycobacterium paratuberculosis and E. coli in the intestinal tissue specimens and blood macrophages obtained from the CD patients. Such a chronic, non-resolved infection may disturb the immune cell properties and affect the balance of pro-inflammatory and anti-inflammatory cytokines, thus resulting into chronic inflammation, a hallmark of Crohn disease.In this view, potential usage of NK cells aimed for influencing macrophage activity represents a new approach in understanding and treatment of autoimmune pathologies. The macrophages are controlled by NK cells. I.e., binding of NKG2D receptor to the MICA molecules on the macrophage surface causes their lysis.A signal transfer via NKG2D receptor may increase functional activity of NK against defective macrophages, and hence, promote their elimination. Moreover, in Crohn patients with usually elevated NKG2D+ lymphocyte numbers, a stimulation of NKG2D+ cells by soluble MICA (sMICA) may influence the balance between cytotoxic and regulatory lymphocytes, and reduce pro-inflammatory cytokine secretion, in order to attenuate chronic inflammation of gut tissues. This review is aimed to discuss a role of NKG2D+ NK cells in Crohn’s disease pathology and their possible implications for management and treatment of this disorder. |
first_indexed | 2024-03-08T05:49:23Z |
format | Article |
id | doaj.art-14b35839d7d04147936c7ec1e475d759 |
institution | Directory Open Access Journal |
issn | 1563-0625 2313-741X |
language | Russian |
last_indexed | 2024-04-24T06:51:45Z |
publishDate | 2017-08-01 |
publisher | St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists |
record_format | Article |
series | Медицинская иммунология |
spelling | doaj.art-14b35839d7d04147936c7ec1e475d7592024-04-22T13:07:42ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2017-08-0119446147010.15789/1563-0625-2017-4-461-470940POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASEE. A. Shulenina0E. V. Abakushina1E. Yu. Lyssuk2Dmitry Rogachev Federal Research Center of Pediatric Hematology, Oncology and Immunology; First Moscow I.M. Sechenov State Medical UniversityA. Tsyb Medical Radiological Research Centre, Branch of National Medical Research Radiological CentreDmitry Rogachev Federal Research Center of Pediatric Hematology, Oncology and Immunology; Institute of Gene Biology, Russian Academy of Sciences; Pirogov Russian National Research Medical UniversityAutoimmune mechanisms of Crohn’s disease have been extensively studied, following discovery of NOD2, ATG16L1, IRGM genetic polymorphisms associated with Crohn’s disease. These genes play an important role in innate immune response against intracellular bacteria, in particular, due to their direct participation in a process known as autophagy. Due to mentioned genetic traits, the CD patients are more susceptible to chronic infections caused by intracellular pathogens. Recent studies revealed high incidence of intracellular infection with Mycobacterium paratuberculosis and E. coli in the intestinal tissue specimens and blood macrophages obtained from the CD patients. Such a chronic, non-resolved infection may disturb the immune cell properties and affect the balance of pro-inflammatory and anti-inflammatory cytokines, thus resulting into chronic inflammation, a hallmark of Crohn disease.In this view, potential usage of NK cells aimed for influencing macrophage activity represents a new approach in understanding and treatment of autoimmune pathologies. The macrophages are controlled by NK cells. I.e., binding of NKG2D receptor to the MICA molecules on the macrophage surface causes their lysis.A signal transfer via NKG2D receptor may increase functional activity of NK against defective macrophages, and hence, promote their elimination. Moreover, in Crohn patients with usually elevated NKG2D+ lymphocyte numbers, a stimulation of NKG2D+ cells by soluble MICA (sMICA) may influence the balance between cytotoxic and regulatory lymphocytes, and reduce pro-inflammatory cytokine secretion, in order to attenuate chronic inflammation of gut tissues. This review is aimed to discuss a role of NKG2D+ NK cells in Crohn’s disease pathology and their possible implications for management and treatment of this disorder.https://www.mimmun.ru/mimmun/article/view/1317nkg2dnkmicamacrophagesautoimmunitycrohn’s disease |
spellingShingle | E. A. Shulenina E. V. Abakushina E. Yu. Lyssuk POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE Медицинская иммунология nkg2d nk mica macrophages autoimmunity crohn’s disease |
title | POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE |
title_full | POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE |
title_fullStr | POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE |
title_full_unstemmed | POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE |
title_short | POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE |
title_sort | potential usage of nk cells and nkg2d positive lymphocytes as targets in therapy of crohn s disease |
topic | nkg2d nk mica macrophages autoimmunity crohn’s disease |
url | https://www.mimmun.ru/mimmun/article/view/1317 |
work_keys_str_mv | AT eashulenina potentialusageofnkcellsandnkg2dpositivelymphocytesastargetsintherapyofcrohnsdisease AT evabakushina potentialusageofnkcellsandnkg2dpositivelymphocytesastargetsintherapyofcrohnsdisease AT eyulyssuk potentialusageofnkcellsandnkg2dpositivelymphocytesastargetsintherapyofcrohnsdisease |